J.BurnP.WoodsS
However, these methods fail to adequately address the shared oxidative mechanisms underlying toxicity, specifically the accumulation of ROS and resulting oxidative stress, which are common consequences of chemotherapeutic agents used in ALL treatment, including anthracyclines, vincristine and 6-MP
In neuroprotection, QUE demonstrates promise in combating neurodegenerative diseases such as Alzheimers and Parkinsons
Among the novel therapies, great interest has been aroused by sodiumglucose cotransporter-2 inhibitors (SGLT2-i) and glucagon-like peptide-1 receptor agonist (GLP1-RA), that have changed the management of diabetic patients
Scheiermann P, Bachmann M, Goren I, Zwissler B, Pfeilschifter J, Mhl H
GLP-1 receptor agonists in Parkinsons disease: an updated comprehensive systematic review with meta-analysis